Your browser doesn't support javascript.
loading
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Feigin, Andrew; Evans, Elizabeth E; Fisher, Terrence L; Leonard, John E; Smith, Ernest S; Reader, Alisha; Mishra, Vikas; Manber, Richard; Walters, Kimberly A; Kowarski, Lisa; Oakes, David; Siemers, Eric; Kieburtz, Karl D; Zauderer, Maurice.
Affiliation
  • Feigin A; New York University Langone Health and The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York, NY, USA.
  • Evans EE; Vaccinex, Inc., Research, Rochester, NY, USA.
  • Fisher TL; Vaccinex, Inc., Research, Rochester, NY, USA.
  • Leonard JE; Vaccinex, Inc., Research, Rochester, NY, USA.
  • Smith ES; Vaccinex, Inc., Research, Rochester, NY, USA.
  • Reader A; Vaccinex, Inc., Research, Rochester, NY, USA.
  • Mishra V; Vaccinex, Inc., Research, Rochester, NY, USA.
  • Manber R; IXICO, London, UK.
  • Walters KA; WCG Statistics Collaborative, Inc., Washington, DC, USA.
  • Kowarski L; WCG Statistics Collaborative, Inc., Washington, DC, USA.
  • Oakes D; University of Rochester Medical Center, Rochester, NY, USA.
  • Siemers E; Siemers Integration LLC, Zionsville, IN, USA.
  • Kieburtz KD; University of Rochester Medical Center, Rochester, NY, USA.
  • Zauderer M; Vaccinex, Inc., Research, Rochester, NY, USA. mzauderer@vaccinex.com.
Nat Med ; 2022 Oct 04.
Article in En | MEDLINE | ID: mdl-36195687

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Document type: Article Affiliation country: